tBrexa's Approach to Regulating Gene Therapy
We are developing immunotherapeutics to treat and/or prevent the reoccurrence of cancers.
Cancer is caused by abnormal cells that grow in an uncontrolled manner. These cells proliferate and metastasize throughout the body causing tumors which can cause organ failure and death. The current treatments such as surgery, radiation, and chemotherapy have limited therapeutic effects and significant undesirable side effects. T-Cell immunotherapy market across the world is expected to reach $30B by 2030.
tBrexa BioSciences Inc.
241 Francis Ave
Mansfield, MA 02048